EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The use of artificial intelligence and machine learning to predict tumor recurrence in high-grade gliomas: a systematic review

Trent Kite, Tushar Nayak, Stephen Jaffee, Mokshal Porwal, Cynthia Han, Praveer Vyas, Aswin Sankaranarayanan, Rodney E Wegner, Pulkit Grover, Matthew J Shepard

Neurosurgical Review · 23.07.2026 · 49 (1)

DOI: 10.1007/s10143-026-04406-7 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurosurgical Review, online erschienen am 23.07.2026. Verfasst von Trent Kite und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Allegheny Health Network Neuroscience Institute, 320 E North Ave, Pittsburgh, PA, 15212, USA. Hauptthemen laut MEDLINE: Glioma, Neoplasm Recurrence, Local, Machine Learning, Brain Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade gliomas (HGGs) are aggressive tumors with a propensity for recurrence. Despite standardized therapies, definitive treatment is elusive. Advancements in artificial intelligence (AI) and machine learning (ML) can potentially identify recurrence probabilities and patterns facilitating individualized therapy. A systematic review was conducted in accordance with the PRISMA guidelines. PubMed, ScienceDirect, and Web of Science databases were queried for reports on the use of AI/ML for the prediction of disease recurrence in HGGs. Using a random-effects model and inverse variance weighting a pooled analysis of key performance metrics (sensitivity, specificity, and accuracy) was conducted on the top performing models from each manuscript. In total, 14 manuscripts encompassing 1,540 patients were selected for systematic review and analysis. Across the included studies, 13/14 (92.9%) were retrospective study designs, with 1/14 (7.1%) prospective study design. Among the 1,540 patients, 1,530 (99.3%) and 10 (0.7%) were histologically classified as WHO grade IV and III respectively. Nine studies (9/14, 64.3%) examined patients undergoing GTR following by adjuvant RT, and five studies (5/14, 35.7%) undergoing STR/NTR followed by adjuvant RT. The Random Forest (RF) model was most frequently utilized, with T2-FLAIR sequences most frequently incorporated into model training. The pooled sensitivity, specificity, and accuracy of the models were 81% (95% CI: 73–87; I² = 85.2%), 75% (95% CI: 65–85; I² = 91.9%), and 79% (95% CI: 64–92; I² = 87.8%), respectively. Following sensitivity analyses, the corresponding estimates were 81% (95% CI: 77–84; I² = 0.0%), 84% (95% CI: 79–88; I² = 38.8%), and 89% (95% CI: 83–95; I² = 0.0%), respectively. The development of an AI/ML model to predict tumor recurrence in HGGs has been an emerging area of research over the past decade. While ongoing validation in larger, prospective databases is needed, preliminary evidence suggests that existing models perform with reasonable sensitivity, specificity, and accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaNeoplasm Recurrence, LocalMachine LearningBrain NeoplasmsArtificial IntelligenceHumansPredictive Learning ModelsNeoplasm GradingRandom ForestPrediction Algorithms

Stichwörter der Autor:innen

Artificial intelligenceHigh-grade gliomaMachine learningNeural networksPrediction

Autor:innen und Institutionen

  • Department of Neurosurgery, Allegheny Health Network Neuroscience Institute, 320 E North Ave, Pittsburgh, PA, 15212, USA.
  • Department of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA.
  • Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
  • Department of Neurosurgery, Allegheny Health Network Neuroscience Institute, 320 E North Ave, Pittsburgh, PA, 15212, USA. Matthew.shepard@ahn.org.

Zitieren

APA

Kite, T., Nayak, T., Jaffee, S., Porwal, M., Han, C., Vyas, P., Sankaranarayanan, A., Wegner, R. E., Grover, P., & Shepard, M. J. (2026). The use of artificial intelligence and machine learning to predict tumor recurrence in high-grade gliomas: a systematic review. Neurosurgical Review, 49(1). https://doi.org/10.1007/s10143-026-04406-7

Vancouver

Kite T, Nayak T, Jaffee S, Porwal M, Han C, Vyas P, et al. The use of artificial intelligence and machine learning to predict tumor recurrence in high-grade gliomas: a systematic review. Neurosurgical Review. 2026;49(1). doi:10.1007/s10143-026-04406-7

BibTeX
@article{Kite2026,
  author = {Kite, Trent and Nayak, Tushar and Jaffee, Stephen and Porwal, Mokshal and Han, Cynthia and Vyas, Praveer and Sankaranarayanan, Aswin and Wegner, Rodney E and Grover, Pulkit and Shepard, Matthew J},
  title = {The use of artificial intelligence and machine learning to predict tumor recurrence in high-grade gliomas: a systematic review},
  journal = {Neurosurgical Review},
  year = {2026},
  volume = {49},
  number = {1},
  doi = {10.1007/s10143-026-04406-7}
}
Kostenlos starten →